We show for the first time a deregulation of RBMS1 in connection with prostate cancer and demonstrate its decline in primary prostate tumours as well as in the PCa cell lines DU145 and LNCaP by qRT-PCR. Here, RBMS1 is linked to prostate carcinoma.